semaglutide news today 2025 Novo Nordisk has announced that the FDA has approved the Wegovy® pill (once-daily oral 25 mg) as the first ever oral GLP-1 receptor agonist therapy for chronic weight management in adults Americans turn to risky unregulated

Retatrutide is not currently approved by the Medicines and Healthcare products Regulatory Agency (MHRA) or the European Medicines Agency (EMA) for routine clinical use in the UK

Retatrutide Dosing Guide Full 2mg to 12mg titration protocol, conservative options, and pharmacokinetics

(Sterility and endotoxin standards reference.) Related peptide guides Ready when you are GHK-Cu (Copper Peptide) A copper peptide studied for skin and tissue support From $179/mo compounded by a licensed 503A pharmacy, dispensed only after provider review

However, if you were on high-dose tirzepatide and switch to semaglutide, the reduced overall potency may result in somewhat less weight suppression long-term